Vanta Bioscience Ltd.
| BSE: 540729 | Sector: Others |
| NSE: N.A. | ISIN Code: INE695X01011 |
| BSE 00:00 | 18 Jun | 149.00 |
-4.30 (-2.80%) |
OPEN
150.00 |
HIGH
152.05 |
LOW
149.00 |
| NSE 05:30 | 01 Jan | Vanta Bioscience Ltd |
| OPEN | 150.00 |
| PREVIOUS CLOSE | 153.30 |
| VOLUME | 12000 |
| 52-Week high | 195.50 |
| 52-Week low | 100.00 |
| P/E | 98.03 |
| Mkt Cap.(Rs cr) | 94 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Vanta Bioscience Ltd. (VANTABIOSCIENCE) - Announcements
-
Vanta Bioscience Ltd Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Audited Finan
17/06/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Intimation Regarding Application Filed Against The Company Before NCLT Under Section 9 Of Insolvency
15/06/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Vayam Research Solutions Limited Ceases To Be A Step Down Subsidiary Of The Company
22/05/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Compliance Certificate Under Regulation 40(9) For Half Year Ended March 31 2021
21/04/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Compliance Certificate Under Regulation 7(3) For The Half Year Ended 31.03.2021
21/04/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Shareholding for the Period Ended March 31 2021
20/04/2021 | bse
-
Vanta Bioscience Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
14/04/2021 | bse
-
Vanta Bioscience Ltd Grant Of Registration By DCGI To Vayam Research Solutions Limited Step Down Subsidiary Of Vanta Bios
12/04/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Closure of Trading Window
31/03/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
08/01/2021 | bse
-
Vanta Bioscience Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
04/01/2021 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Unaudited Financial Results For The Half Year Ended 30.09.2020
13/11/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Board Meeting Intimation for Approving The Un-Audited Financial Statements For The Half Year Ended S
05/11/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Shareholding for the Period Ended September 30 2020
16/10/2020 | bse
-
Vanta Bioscience Ltd Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations 2015 For Half Year Ended Sep
16/10/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015 For Half Year Ended Se
16/10/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Statement Of Investor Complaints For The Quarter Ended September 2020
07/10/2020 | bse
-
Vanta Bioscience Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
01/10/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM
01/10/2020 | bse |
Downlaod PDF -
Vanta Bioscience Ltd Closure of Trading Window
30/09/2020 | bse |
Downlaod PDF
Quick Links for Vanta Bioscience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
